Artelo Biosciences, Inc. (ARTL) News
Track canonical SquawkNews coverage tagged to ARTL, Artelo Biosciences, Inc.. This hub brings together deduplicated headlines about alpaca us equities, markets catalysts, earnings, analyst actions, and wider market events so traders can review how a developing story changed over time. It contains 4 indexed stories across 4 publication days and is ordered by the same first-publication timeline used by LiveCast.
L
Artelo Biosciences reports 2026 second-quarter results
Artelo Biosciences (ARTL) provides a business update and reports its 2026 second-quarter financial results, according to TradeXchange Newsdesk.
EARNINGS | Aug 13, 2026, 12:02 PM UTC
L
ARTL Artelo Biosciences announces results from a nonclinical osteoarthritis study supporting art26.12 as a potential first-in-class new ther
ARTL Artelo Biosciences announces results from a nonclinical osteoarthritis study supporting art26.12 as a potential first-in-class new therapy for chronic pain conditions
EQUITY | Jul 16, 2026, 12:48 PM UTC
L
Artelo Biosciences Announces Data From Preclinical Trial In Neuropathic Pain From Spinal Cord Injury Shows Lowered Mechanical Hypersensitivi
Artelo Biosciences, Inc. (Nasdaq: ARTL) ("Artelo" or the "Company"), a clinical-stage pharmaceutical company focused on modulating lipid-signaling pathways to develop treatments for people living with cancer, pain, derma
EQUITY | Jul 01, 2026, 12:43 PM UTC
L
Artelo Biosciences Identifies Lipid Pathway Link For ART26.12 In Multi-Omics Cancer Research Presentation At The CRS 2026 Annual Symposium
Artelo Biosciences, Inc. (Nasdaq: ARTL), a clinical-stage pharmaceutical company focused on modulating lipid-signalling pathways to develop treatments for people living with cancer, pain, dermatologic, or neurological co
EQUITY | Jun 30, 2026, 12:59 PM UTC